News and publishing service for medical and biotechnology related companies
Contact us:
512.354.7000
twitter
facebook
linkedin
News and publishing service for medical and biotechnology related companies
Home
About
Clients
NewsRoom
Solutions
Events
Contact
Headlines
The 47% Signal: Why Earth Science Tech Inc.’s (ETST) Management Is Betting the House on ETST
Soligenix (NASDAQ: SNGX) Positioning for Impact in Growing Rare-Disease Landscape
Circadian Regulation Could Boost Cancer Immunotherapy, New Study Finds
New Compound Could Become a Transformational Brain Cancer Pill
The US Formally Exits the World Health Organization
BioMedNewsBreaks
BioMedNewsBreaks — Soligenix Inc. (NASDAQ: SNGX) Highlights HyBryte Clinical Data In Peer-Reviewed Journal Publication
Soligenix Inc. (SNGX)
March 19, 2026
BioMedNewsBreaks — Soligenix Inc. (NASDAQ: SNGX) Featured On BioMedWire Podcast Highlighting Phase 3 HyBryte Progress And Key Inflection Points
Soligenix Inc. (SNGX)
March 19, 2026
BioMedNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Partners With NeuroRPM To Integrate AI Platform In Parkinson Study
Annovis Bio Inc. (ANVS)
March 19, 2026
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Secures Costa Rica Approval for Kinesiology Tape Line
Nutriband Inc. (NTRB)
March 18, 2026
BioMedNewsBreaks — NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives FDA Feedback On Bioequivalence For Ketamine Product
NRx Pharmaceuticals, Inc. (NRXP)
March 17, 2026
View More BioMedNewsBreaks
BioMedWire Articles
Study Finds That Marijuana Legalization Lowers Crime Rates
Astiva Health
March 19, 2026
Earth Science Tech Inc. (ETST) Builds Telehealth, Pharmacy Links in Evolving Digital Care
Earth Science Tech Inc. (ETST)
March 18, 2026
Soligenix Inc. (NASDAQ: SNGX) Advances Rare Disease Innovation Through Platform Science and Expanding Therapeutic Pipeline
Soligenix Inc. (SNGX)
March 18, 2026
Mirror-Image Amino Acid Shows Promise in Starving Cancer Cells
CNS Pharmaceuticals Inc. (CNSP)
March 17, 2026
Investing in Innovation: Evaluating the Clinical and Commercial Potential of LB-100 and Liora’s Proton Therapy
Lixte Biotechnology Holdings, Inc. (LIXT)
March 16, 2026
View All BioMedWire Articles
Public Press Releases
Filter Releases
Filters
Sector
Aerospace and Defense
Banking and Finance
Banking
Biotechnology
Internet
Media
Metal and Mineral
Chemicals
Computer
Consumer Goods
Pharmaceutical
Oil & Energy
Real Estate
Software
Energy
Entertainment
Food and Beverage
Healthcare
Telecommunications
Transportation
Utilities
Remove All Filters
Symbol
Release
Time
Source
{{ release.qmtopics.qmsymbol[0].symbol }}
{{ release.headline }}
{{ release.datetime | amDateFormat:'hh:mm A'}}
{{ release.source }}
Load More
Official NewsWire Relationships
BioMedWire Currently Accepts
Bitcoin
Bitcoin Cash
Ethereum
Litecoin
USD Coin
Contact us:
512.354.7000